RELMADA THERAPEUTICS, INC. — Director's Dealing 2015

Dec 17, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RELMADA THERAPEUTICS, INC. (RLMD)
CIK: 0001553643
Period of Report: 2015-12-15

Reporting Person: TRAVERSA SERGIO (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-12-15	Common stock	P	241	$2.92	Acquired	320593	Direct
2015-12-15	Common stock	P	2759	$2.99	Acquired	323352	Direct
2015-12-15	Common stock	P	2370	$2.98	Acquired	325722	Direct
2015-12-15	Common stock	P	5600	$2.91	Acquired	331322	Direct
2015-12-15	Common stock	P	4358	$3.00	Acquired	335680	Direct
2015-12-15	Common stock	P	1600	$3.40	Acquired	337280	Direct
2015-12-15	Common stock	P	42	$3.39	Acquired	337322	Direct
2015-12-15	Common stock	P	200	$3.34	Acquired	337522	Direct
2015-12-15	Common stock	P	1800	$3.42	Acquired	339322	Direct